You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

LY231514

Showing 1 - 25 of 137
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC Trial in Guangzhou (Avitinib Maleate, Afatinib, Crizotinib)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Avitinib Maleate
  • +13 more
  • Guangzhou, Guangdong, China
    Guangdong Lung Cancer Institute, Guangdong Provincial People's H
Dec 3, 2022

Lung Cancer Trial in Houston (AMG 510, Cisplatin, Carboplatin)

Recruiting
  • Lung Cancer
  • AMG 510
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 10, 2022

Non Small Cell Lung Cancer, NSCLC, Stage III, Nsclc Trial in Stanford (Durvalumab, Carboplatin, Pemetrexed)

Recruiting
  • Non Small Cell Lung Cancer
  • +2 more
  • Stanford, California
    Stanford University
Oct 27, 2022

Advanced Cancers Trial in Houston (Crizotinib (Xalkori), Pazopanib, Pemetrexed)

Terminated
  • Advanced Cancers
  • Crizotinib (Xalkori)
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 3, 2021

Metastatic Salivary Gland Carcinoma, Recurrent Salivary Gland Carcinoma, Stage IV Major Salivary Gland Cancer AJCC v8 Trial in

Recruiting
  • Metastatic Salivary Gland Carcinoma
  • +5 more
  • Pembrolizumab
  • Pemetrexed Disodium
  • Scottsdale, Arizona
  • +2 more
Mar 15, 2022

Brain and CNS Tumors, Chronic Myeloproliferative Disorders, Leukemia Trial in Chicago (Pemetrexed)

Completed
  • Brain and Central Nervous System Tumors
  • +10 more
  • Chicago, Illinois
    Robert H. Lurie Comprehensive Cancer Center at Northwestern Univ
Sep 3, 2021

Metastatic Urothelial Carcinoma Trial in Houston (Laboratory Biomarker Analysis, Pemetrexed Disodium)

Terminated
Has Results
  • Metastatic Urothelial Carcinoma
  • Laboratory Biomarker Analysis
  • Pemetrexed Disodium
  • Houston, Texas
    M D Anderson Cancer Center
May 18, 2021

Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma Trial in Bronx, New York

Completed
Has Results
  • Recurrent Fallopian Tube Carcinoma
  • +2 more
  • Bronx, New York
  • +2 more
Oct 18, 2021

Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage IA1 Lung Cancer AJCC v8 Trial in San Francisco (drug,

Withdrawn
  • Lung Non-Small Cell Carcinoma
  • +9 more
  • San Francisco, California
    University of California, San Francisco
Feb 17, 2022

Rectal Cancer Trial in Göteborg ([6R] 5,10-methylenetetrahydrofolate (arfolitixorin), Pemetrexed)

Completed
  • Rectal Cancer
  • [6R] 5,10-methylenetetrahydrofolate (arfolitixorin)
  • Pemetrexed
  • Göteborg, Sweden
    Sahlgrenska University Hospital
Sep 7, 2020

Recurrent NSCLC, Stage IV NSCLC Trial in Detroit (docetaxel, pemetrexed disodium, gemcitabine HCl)

Terminated
Has Results
  • Recurrent Non-small Cell Lung Cancer
  • Stage IV Non-small Cell Lung Cancer
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
Sep 3, 2020

NSCLC Trial in United States (enzastaurin, pemetrexed, docetaxel)

Completed
Has Results
  • Non-Small Cell Lung Cancer
  • Burlington, North Carolina
  • +3 more
Apr 20, 2021

Recurrent NSCLC, Squamous Cell Lung Cancer, Stage IV NSCLC Trial in Los Angeles (Hsp90 inhibitor AUY922, pemetrexed disodium,

Completed
  • Recurrent Non-small Cell Lung Cancer
  • +2 more
  • Hsp90 inhibitor AUY922
  • +3 more
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center
Sep 1, 2020

Stage II NSCLC AJCC v7, Stage IIA Non-Small Cell Lung Carcinoma AJCC v7, Stage IIB Non-Small Cell Lung Carcinoma AJCC v7 Trial

Recruiting
  • Stage II Non-Small Cell Lung Cancer AJCC v7
  • +5 more
  • Jacksonville, Florida
  • +29 more
Dec 15, 2022

Bronchioloalveolar Carcinoma, Large Cell Lung Carcinoma, Lung Adenocarcinoma Trial in Sacramento, Worcester, Bronx (Erlotinib

Completed
Has Results
  • Bronchioloalveolar Carcinoma
  • +5 more
  • Erlotinib Hydrochloride
  • +2 more
  • Sacramento, California
  • +4 more
Aug 28, 2020

Non Small Cell Lung Cancer Trial in Worldwide (Pemetrexed, Cisplatin, Necitumumab)

Completed
Has Results
  • Non Small Cell Lung Cancer
  • Nyack, New York
  • +100 more
Dec 12, 2021

NSCLC Trial in United States (enzastaurin, pemetrexed, carboplatin)

Completed
Has Results
  • Non-small Cell Lung Cancer
  • Bentonville, Arkansas
  • +11 more
Apr 20, 2021

Solid Tumor Trial in Rochester (drug, other, procedure)

Completed
  • Unspecified Adult Solid Tumor, Protocol Specific
  • Rochester, Minnesota
    Mayo Clinic
Apr 4, 2019

Lung Cancer Trial in Worldwide (enzastaurin, pemetrexed, cisplatin)

Terminated
Has Results
  • Lung Cancer
  • Leuven, Belgium
  • +11 more
Oct 9, 2020

Lung Cancer Trial in Houston (Carboplatin, Pemetrexed, Bevacizumab)

Completed
Has Results
  • Lung Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
May 13, 2019

Solid Tumors Trial in New Brunswick (LY573636, Pemetrexed)

Completed
Has Results
  • Solid Tumors
  • New Brunswick, New Jersey
    For additional information regarding investigative sites for thi
Dec 1, 2018

Stage IV NSCLC Trial in Los Angeles (drug, other, procedure)

Completed
  • Stage IV Non-small Cell Lung Cancer
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center
May 3, 2019

Advanced Cancer Trial in Bruderholz (LY2603618, Pemetrexed, Gemcitabine)

Completed
Has Results
  • Advanced Cancer
  • Bruderholz, Switzerland
    For additional information regarding investigative sites for thi
Dec 12, 2018

Advanced Cancer Trial in Tampa, Nashville (LY2090314, pemetrexed, Carboplatin)

Completed
Has Results
  • Advanced Cancer
  • Tampa, Florida
  • +1 more
Oct 17, 2018

NSCLC Trial in Worldwide (Pembrolizumab SC, Pembrolizumab IV, Paclitaxel)

Recruiting
  • Non-Small Cell Lung Cancer
  • Pembrolizumab SC
  • +6 more
  • Jonesboro, Arkansas
  • +116 more
Aug 5, 2022